Podcasts about Exclusion

The global disability market represents a staggering $18 trillion dollars in spending power. And in this powerful episode, Tiffany Yu, founder of Diversability, TEDx speaker, and author of The Anti-Ableist Manifesto is sharing how she turned her own disability into a global movement for inclusion. After a car accident made her disabled and took her father's life, Tiffany eventually found the courage more than a decade later to share her story, helping others unlearn shame and embrace their own identities.You'll hear how Tiffany built Diversability from a college club into a thriving international community, why employers must rethink job descriptions and office norms to foster true accessibility, and how storytelling paired with data can radically shift public perception.If you want to build more inclusive communities, Tiffany's magnetic energy and practical wisdom will inspire you to see lived experience as a superpower rather than a limitation.Resources & LinksConnect with Tiffany on her website, order her book, The Anti-Ablelist Manifesto, and watch her TED talk, The Power of Exclusion.  This show is brought to you by iDonate. Your donation page is leaking donors, and iDonate's new pop-up donation form is here to fix that. See it in action. Launch the interactive demo here and experience how a well-timed form captures donors in the moment they care most. Let's Connect! Send a DM on Instagram or LinkedIn and let us know what you think of the show! My book, The Monthly Giving Mastermind, is here! Grab a copy here and learn my framework to build, grow, and sustain subscriptions for good. Want to book Dana as a speaker for your event? Click here!

"The NPP party's collapse and loss of appeal are clear. To rebuild trust, all party executives—from Afenyo Markins to Annoh-Dompreh—must be dissolved. Former President Kufuor has worked tirelessly for the party and doesn't deserve to be sidelined."

New Discourses Bullets, Ep. 119 We're inundated with messages that somehow "diversity is our strength" and the path to that strength and growth is through "inclusion." We also know that term is a Communist scam, and we've talked about that at length in the past, repeatedly. Well, it's time for a defense of exclusion as it is rightly meant by Communists, specifically the "fundamental right to exclude," which is a pillar of what defines private property. In this episode of New Discourses Bullets, host James Lindsay explains how this property, the fundamental right to exclude, is the basis for all wealth. It's not just an important episode to catch but one that's crucial to share with your kids who aren't getting these lessons at school. New book! The Queering of the American Child: https://queeringbook.com/ Support New Discourses: https://newdiscourses.com/support Follow New Discourses on other platforms: https://newdiscourses.com/subscribe Follow James Lindsay: https://linktr.ee/conceptualjames © 2025 New Discourses. All rights reserved. #NewDiscourses #JamesLindsay #exclusion

Listen as Michael S. Benninger, MD, describes his approach to the diagnosis and management of chronic cough and refractory chronic cough in the context of a clinically relevant case.PresenterMichael S. Benninger, MDProfessor of Otolaryngology-Head and Neck SurgeryLerner College of MedicineThe Cleveland ClinicPresident, International Association of PhonosurgeryCleveland, OhioLink to full program:https://bit.ly/4kweynG

Un projet d'attentat a été déjoué le mardi 1er juillet à Saint-Etienne, avec l'arrestation d'un jeune homme âgé de 18 ans. Le suspect se revendique « incel », pour « involuntary celibate », une mouvance masculiniste et misogyne. Anne de Guigné et Sophie Obadia reviennent sur cet événement, ainsi que les motivations du jeune homme. Mention légales : Vos données de connexion, dont votre adresse IP, sont traités par Radio Classique, responsable de traitement, sur la base de son intérêt légitime, par l'intermédiaire de son sous-traitant Ausha, à des fins de réalisation de statistiques agréées et de lutte contre la fraude. Ces données sont supprimées en temps réel pour la finalité statistique et sous cinq mois à compter de la collecte à des fins de lutte contre la fraude. Pour plus d'informations sur les traitements réalisés par Radio Classique et exercer vos droits, consultez notre Politique de confidentialité.Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

Ghanaians observed National Prayers and Thanksgiving Day with Christian and Islamic leaders present, while traditionalists were not officially invited. Nuumo Blafo expressed no grievance, emphasizing unity and respect for all faiths and welcoming everyone regardless of invitation

This lecture by the 2025 Nils Klim Laureate Daniela Alaattinoğlu was held as part of the Nils Klim Symposium: ‘Nordic Right Development from the Margins? Reassessing Legal Inclusion and Exclusion.' , which took place in the University Aula in Bergen, on 3 June 2025. Alaattinoğlu asks: How can experiences often marginalised in legal discussions enrich current accounts of Nordic rights developments? Daniela Alaattinoğlu is Assistant Professor of Law at the University of Turku and the recipient of the 2025 Nils Klim Prize.

Next Tuesday the IHC - which advocates for the rights, inclusion and welfare of people with intellectual disabilities will offiicially launch its new report entitled The Cost of Exclusion.

In this episode of then & now, we are joined by Dr. Jamaal Muwwakkil, Chancellor's Postdoctoral Fellow at UCLA and incoming Assistant Professor of Anthropology at the University of Washington, to discuss the recent rollback of affirmative action and diversity, equity, and inclusion (DEI) initiatives in American universities. Jamaal examines how these changes—set in motion by the Supreme Court's 2023 decision to end race-conscious admissions, alongside a rising political backlash against DEI, particularly from the Trump administration—signal a return to exclusionary practices after decades of hard-fought progress. Bringing a sociolinguistic perspective to the jagged history of Black student experiences in the era of affirmative action, Jamaal traces the arc from the first efforts at inclusion in the 1950s to the present moment. Focusing on the implications of these shifts, particularly for Black and Latinx students navigating the current higher education environment, Jamaal provides insight into how language, policy, and power shape experiences of belonging and exclusion on campus, offering essential context for understanding this pivotal moment in higher education.Dr. Jamaal Muwwakkil is a University of California Chancellor's Postdoctoral Fellow at UCLA in the Department of Education and Information Studies and an incoming Assistant Professor of Anthropology at the University of Washington. Jamaal holds a Linguistics PhD from the University of California, Santa Barbara. He was also the 2019-20 University of California (UC) Student Regent-designate and the 2020-21 UC Student Regent. Jamaal's research specializations include African American language and culture, sociocultural linguistics, and political discourse.

THE LANCET 2003;362:772-776Background: Angiotensin converting enzyme inhibitors (ACEi) reduce mortality and morbidity in patients with systolic heart failure (see CONSENSUS and SOLVD trials). However, registry data showed that up to 20% of patients with systolic heart failure were not taking ACEi. One of the frequent causes for intolerance to ACEi is cough. Angiotensin converting enzyme inhibitors work by blocking the conversion of angiotensin I to angiotensin II, a key step in the renin–angiotensin–aldosterone system (RAAS). Angiotensin II receptor blockers were tolerated in patients with systolic heart failure who were intolerant to ACEi. However, data on long term effectives as an alternative to ACEi were lacking.Cardiology Trial's Substack is a reader-supported publication. To receive new posts and support our work, consider becoming a free or paid subscriber.The Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Alternative trial sough to assess if the angiotensin-receptor blocker (ARB) candesartan, could improve outcomes in patients with systolic heart failure who are intolerant to ACEi.Patients: Eligible patients had left ventricular ejection fraction of 40% or less and NYHA class II, III or IV symptoms of at least 4 weeks duration. Patients had also to be intolerant to ACEi.Exclusion criteria were not provided in the main manuscript.Baseline characteristics: Patients were recruited from 618 centers in 26 countries. The trial randomized 2,028 patients – 1,013 randomized to receive candesartan and 1,015 to receive placebo.The average age of patients was 67 years and 68% were men. The average left ventricular ejection fraction was 30%. Cardiomyopathy was ischemic in 68% of the patients. The NYHA class was II in 48% of the patients, III in 49% and IV in 4%.Approximately 50% had hypertension, 27% had diabetes, 61% had prior myocardial infarction, 9% had stroke, 25% had atrial fibrillation and 14% were current smokers.At the time of enrollment, 85% were taking a diuretic, 46% were taking digoxin, 55% were taking beta-blockers and 24% were taking spironolactone.The most common reasons for ACEi intolerance were cough in 72% of the patients, hypotension in 13%, renal dysfunction in 12% and angioedema or anaphylaxis in 4%.Procedures: The trial was double-blinded. Patients were assigned in a 1:1 ratio to receive candesartan starting at 4 or 8mg once daily or placebo. The treatment was doubled every two weeks to a target dose of 32mg once daily.After randomization, follow up occurred at 2, 4, and 6 weeks, 6 months and every 4 months thereafter.Endpoints: The primary outcome was a composite of cardiovascular death or heart failure hospitalizations. All deaths were classified as cardiovascular unless there was a clear non-cardiac cause.Analysis was performed based on the intention-to-treat principle. The estimated sample size to have 80% power at 5% alpha was 2,000 patients. The sample size calculation assumed 18% relative risk reduction in the primary outcome with candesartan assuming a 15% annual event rate in the placebo arm.Results: The median follow up time was 34 months. The mean candesartan daily dose was 23mg at 6 months.Candesartan reduced the primary endpoint of cardiovascular death or heart failure hospitalizations (33.0% vs 40.0%, adjusted HR: 0.70, 95% CI: 0.60 – 0.81; p< 0.001). Candesartan reduced the individual components of the primary outcome - (21.6% vs 24.8%; p= 0.02) for cardiovascular death and (20.4% vs 28.2%; p< 0.001) for heart failure hospitalizations. All-cause death was also lower with candesartan (26.2% vs 29.2%, adjusted HR: 0.83, 95% CI: 0.70–0.99; p= 0.033). The number of patients who had any hospitalization as well as the total number of hospitalizations were numerically but not statistically significantly lower with candesartan (60.2% with candesartan vs 63.3%; p= 0.16) and (1,718 vs 1,835; p= 0.06).Candesartan was associated with more hypotension (3.7% vs 0.9%), more increase in creatinine (6.1% vs 2.7%) and more hyperkalemia (1.9% vs 0.3%). Angioedema occurred in three patients in the candesartan group and none in the placebo group. Cough occurred in two patients taking candesartan and four taking placebo.Authors reported no significant subgroup interactions, however, a corresponding graph was not provided.Conclusion: In patients with systolic heart failure who are intolerant to ACEi, candesartan reduced the primary composite outcome of cardiovascular death or heart failure hospitalizations with a number needed to treat of approximately of 14 patients over 34 months of follow up. Candesartan also reduced all-cause death with a number needed to treat of approximately 33 patients. Adverse events including hypotension, increase in creatinine and hyperkalemia were more common with candesartan.The reduction in the primary endpoint with candesartan was significant and offers an alternative for patients who are unable to tolerate ACEi. Of note, 72% of the patients enrolled in the trial were intolerant to ACEi due to cough. This trial did not include a head-to-head comparison between ARBs and ACEi, and therefore does not address which agent should be preferred as first-line therapy. Only 24% of participants were receiving spironolactone. The combination of ARBs with spironolactone, may increase the risk of adverse events, particularly hyperkalemia and kidney injury.Cardiology Trial's Substack is a reader-supported publication. To receive new posts and support our work, consider becoming a free or paid subscriber. Get full access to Cardiology Trial's Substack at cardiologytrials.substack.com/subscribe

Montana physical therapists are concerned that Medicaid reimbursement rates are not meeting even the cost of their care, and that a bipartisan bill was recently vetoed that would have made some key adjustments. Click on the podcast to hear from […] The post Physical Therapists Concerned Reimbursement Rates May Force Patient Exclusion, Clinic Closures first appeared on Voices of Montana.

Ronan is an independent scientist, environmentalist and writer.About Gerry: My main interests are in disease, immunity and the discovery of chemotherapeutic compounds00:00 Introduction and Guest Introduction00:15 Overview of the COVID-19 Paper02:36 Background of the Authors and Initial Work03:27 Scientific Approach to COVID-1904:58 Challenges in Questioning the Science09:38 Government Policies and Model Predictions17:44 Sweden's Unique Approach20:32 Publication Challenges and Shifting Narratives22:14 Unintended Consequences of Policies26:27 Precautionary Principle and Logical Fallacies31:56 Great Barrington Declaration and Scientific Dissent45:37 Public Perception and Media Influence49:51 Introduction to Vaccine Narratives50:12 Public Response and Social Dynamics51:23 Questioning Public Health Directives52:50 Media and Information Control53:32 Discussion on Ivermectin and Vaccines54:35 Exploring Ancient Irish Ethnopharmacology55:08 The Role of Streptomyces in Medicine01:01:35 Mathematical Models and Policy Decisions01:09:12 Seasonality and Stringency of COVID Measures01:16:44 Pharmaceutical Interventions and Controversies01:26:16 WHO's Ivermectin and Remdesivir Analysis01:26:44 Exclusion of Ivermectin Studies01:29:50 HCQ Trials and Data Issues01:32:50 Public Perception and Media Influence01:37:23 Vaccine Technology and Public Awareness01:48:54 Adverse Reactions and Reporting02:02:20 Final Thoughts and RecommendationsRonan's X: https://x.com/1RonanConnollyGerry's X: https://x.com/jercuinnFrom Ronan: The paper (37 co-authors) covers many topics, but this 28 min Alex Newman interview gives a great overview of our key findings: https://x.com/1RonanConnolly/status/1932831388790624445The paper itself: https://www.ssph-journal.org/journals/international-journal-of-public-health/articles/10.3389/ijph.2025.1607727/full—AI summaries of all of my podcasts: https://tomn.substack.com/p/podcast-summariesMy Linktree: https://linktr.ee/tomanelson1

Web: www.JonesHealthLaw.comPhone: (305)877-5054Instagram: @JonesHealthLawFacebook: @JonesHealthLawYouTube: @JonesHealthLawThe Centers for Medicare & Medicaid Services (CMS) established the Preclusion List under its authority to administer Medicare Advantage (MA) and Part D programs. The list features healthcare providers and prescribers who are precluded from receiving payment for items or services furnished to Medicare beneficiaries enrolled in MA plans or for prescriptions covered under Part D.The U.S. Department of Health and Human Services, Office of Inspector General (OIG) maintains the List of Excluded Individuals and Entities (LEIE) under the authority of the Social Security Act §§ 1128 and 1156. Exclusions are imposed on individuals or entities found to have engaged in certain misconduct, such as fraud or patient abuse.

The Lancet Volume 353, Issue 9146 p9-13 January 02, 1999Background: Accumulating data at the time suggested functional benefits of antagonism of beta-adrenoreceptors in patients with heart failure. Multiple specific beta-blockers were being tested in trials. The CIBIS 1 trial found a trend towards 20% lower mortality in the bisoprolol (a highly cardio-selective beta-blocker) group and 30% fewer admissions to hospital for worsening heart failure. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II) trial was designed to test this evidence further.Patients Eligible patients had New York Heart Association Class III-IV symptoms with LVEF ≤ 35% and were stable on diuretics and ACE-inhibitors. Exclusion criteria included recent MI or coronary intervention, AV block or resting heart rate less 60 bpm and systolic BP < 100 mmHg. Patients already on beta-blockers or with planned therapy with beta-blockers were also not enrolled.Cardiology Trial's remains independent, free of industry ads, due to reader generosity. Please consider becoming a free or paid subscriber.Baseline Characteristics The mean age of patients was 61 years, 81% male, and 83% Class III. The mean LVEF was 28%. About half the patients had ischemic heart disease, 12% primary dilated cardiomyopathy and nearly 40% had a mixture of valvular heart disease, hypertensive heart disease or unproven ischemic disease.The mean SBP on enrollment was 130 mmHg and resting HR was 80 bpm. The mean duration of heart failure before enrollment was 3.5 years. About 20% had AF at baseline. Nearly all patients were on ACE-I and half were on digoxin.Trial Procedures There was no run-in period. CIBIS II was double blinded. Slightly more than 2,600 patients were randomized 1:1 to bisoprolol or placebo in 274 hospitals across 18 countries.Patients in the bisoprolol group were started at 1.25 mg daily and titrated up weekly to as high as 10 mg daily. The goal was to attempt the highest tolerated dose. Patients were seen every 3 months.Endpoints The primary endpoint was all-cause mortality. Secondary endpoints included all-cause hospital admissions, cardiovascular mortality, combined CV death and CV hospital admissions, and premature treatment withdrawals.The authors estimated a 11.2% mortality in the placebo group and powered the trial to find a 25% reduction in death in the bisoprolol arm over 2 years.Results The trial was sopped early (mean follow-up 1.3 years) after the planned second interim analysis for benefit. The primary outcome of all-cause death occurred in 11.8% in the bisoprolol group vs 17.3% in the placebo arm (HR 0.66 (95% CI 0.54-0.81, p < 0.0001)).Bisoprolol reduced sudden death (3.6% vs 6.3%), all-cause hospitalization (33% vs 39%), CV death (9% vs 12%). Permanent treatment withdrawal occurred in 15% of both arms.The subgroup analysis showed no substantial treatment heterogeneity. The most common dose was 10 mg daily reached in 43% of patients.Conclusion The 34% reduction in death was clinically meaningful and statistically robust. Our confidence in such a large effect size stems from a) previous data on beta-blockers, which found similar effects, b) the 42% reduction in sudden death in the bisoprolol arm and c) the large reductions in all-cause hospitalization. In addition, the trial conduct appeared strong with almost no lost-to-follow up. The lack of run-in period strengthens the external validity of CIBIS II.The same caveats seen in the US carvedilol trial also apply to CIBIS II, namely that patients were ambulatory, outpatients, mostly with Class III symptoms. Patients enrolled in the trial had a mean SBP of 130 mmHg and a resting heart rate of 80. Nearly all patients were tolerating ACE-I and half were taking digoxin. In addition, patients were started on low-dose and gradually titrated higher. The majority of patients were on higher than 5 mg daily.The authors warned against applying these results to non-ambulatory patients with Class IV symptoms, especially if there was recent instability. Get full access to Cardiology Trial's Substack at cardiologytrials.substack.com/subscribe

Miroslav Volf is a theologian and professor at Yale Divinity School, where he is the founding director of the Yale Center for Faith and Culture. He is widely known for his work on reconciliation, forgiveness, and the intersection of faith and public life. He’s the author of at least twelve books, including the highly influential Exclusion and Embrace, as well as many articles and quite a few co-authored books. His most recent book is The Cost of Ambition: How Striving to Be Better than Others Makes Us Worse. In this episode, Dr. Volf and Jonathan Rogers talk about the difference between striving for excellence and striving for superiority. They talk about the freedom to be found when we stop defining ourselves in terms of our status relative to others. Also, they talk a good bit about Satan. This episode is sponsored by The Habit's Short Story Summer Camp, a six-week online writing class devoted to the short story. Find out more at TheHabit.co/ShortStory.Support the show: https://therabbitroom.givingfuel.com/memberSee omnystudio.com/listener for privacy information.

On commence avec l'exclusion officielle de Nicolas Sarkozy de la légion d'honneur, paru ce dimanche au Journal Officiel

Democracy scholars often assume that ethnic homogeneity is good for democracy. Politically mobilised ethnic minorities, the assumption goes, stoke divisions and can destabilise democracy. In his latest book Ethnic Minorities, Political Competition, and Democracy: Circumstantial Liberals (Oxford UP 2024), Jan Rovny turns this assumption on its head and argues that not only minorities are not bad for democracy but in fact they can help strengthen and protect it. In this episode, he talks with host Licia Cianetti about why this is the case, under what circumstances, and how the book's lessons from minorities in Central and Eastern Europe can travel well beyond the region and might even provide insights to interpret recent voting patterns in the US. Jan Rovny is Professor of Political Science at the Center for European Studies and Comparative Politics at Sciences Po, Paris. Licia Cianetti is Lecturer in Political Science and International Studies at the University of Birmingham and Deputy Founding Director of CEDAR. Her book on these themes is The Quality of Divided Democracies: Minority Inclusion, Exclusion and Representation in the New Europe (University of Michigan Press, 2019). The People, Power, Politics podcast brings you the latest insights into the factors that are shaping and re-shaping our political world. It is brought to you by the Centre for Elections, Democracy, Accountability and Representation (CEDAR) based at the University of Birmingham, United Kingdom. Join us to better understand the factors that promote and undermine democratic government around the world. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

Democracy scholars often assume that ethnic homogeneity is good for democracy. Politically mobilised ethnic minorities, the assumption goes, stoke divisions and can destabilise democracy. In his latest book Ethnic Minorities, Political Competition, and Democracy: Circumstantial Liberals (Oxford UP 2024), Jan Rovny turns this assumption on its head and argues that not only minorities are not bad for democracy but in fact they can help strengthen and protect it. In this episode, he talks with host Licia Cianetti about why this is the case, under what circumstances, and how the book's lessons from minorities in Central and Eastern Europe can travel well beyond the region and might even provide insights to interpret recent voting patterns in the US. Jan Rovny is Professor of Political Science at the Center for European Studies and Comparative Politics at Sciences Po, Paris. Licia Cianetti is Lecturer in Political Science and International Studies at the University of Birmingham and Deputy Founding Director of CEDAR. Her book on these themes is The Quality of Divided Democracies: Minority Inclusion, Exclusion and Representation in the New Europe (University of Michigan Press, 2019). The People, Power, Politics podcast brings you the latest insights into the factors that are shaping and re-shaping our political world. It is brought to you by the Centre for Elections, Democracy, Accountability and Representation (CEDAR) based at the University of Birmingham, United Kingdom. Join us to better understand the factors that promote and undermine democratic government around the world. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/political-science

THE LANCET 2003;362:767-771Background: Angiotensin II which plays a role in ventricular remodeling and progression of heart failure can be produced by pathways independent of angiotensin convening enzyme. Preliminary studies showed that the combination of angiotensin II blockers with angiotensin-converting enzyme inhibitors (ACEi) improves hemodynamics and reduces ventricular remodeling.Cardiology Trial's Substack is a reader-supported publication. To receive new posts and support our work, consider becoming a free or paid subscriber.The Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial sough to assess if adding the angiotensin-receptor blocker (ARB), candesartan, to ACEi could improve outcomes in patients with systolic heart failure.Patients: Eligible patients had left ventricular ejection fraction of 40% or less within the previous 6 months, and NYHA class II, III or IV symptoms. Patients with NYHA class II symptoms had to have cardiac-related hospitalization within 6 months. Patients also had to have treatment with ACEi at a constant dose for at least 30 days.Exclusion criteria were not provided in the main manuscript.Baseline characteristics: Patients were recruited from 618 centers in 26 countries. The trial randomized 2,548 patients – 1,276 randomized to receive candesartan and 1,272 to receive placebo.The average age of patients was 64 years and 79% were men. The average left ventricular ejection fraction was 28%. Cardiomyopathy was ischemic in 62% of the patients. The NYHA class was II in 24% of the patients, III in 73% and IV in 3%.Approximately 48% had hypertension, 30% had diabetes, 56% had prior myocardial infarction, 9% had stroke, 27% had atrial fibrillation and 17% were current smokers.At the time of enrollment, 90% were taking a diuretic, 58% were taking digoxin, 55% were taking beta-blockers, 17% were taking spironolactone and all but two patients were taking ACEi.Procedures: The trial was double-blinded. Patients were assigned in a 1:1 ratio to receive candesartan starting at 4 or 8mg once daily or placebo. The treatment was doubled every two weeks to a target dose of 32mg once daily.After randomization, follow up occurred at 2, 4, and 6 weeks, 6 months and every 4 months thereafter.Endpoints: The primary outcome was a composite of cardiovascular death or heart failure hospitalizations. All deaths were classified as cardiovascular unless there was a clear non-cardiac cause.Analysis was performed based on the intention-to-treat principle. The estimated sample size to have 80% power at 5% alpha was 2,300 patients. The sample size calculation assumed 16% relative risk reduction in the primary outcome with candesartan assuming an 18% annual event rate in the placebo arm.Results: The median follow up time was 41 months. The mean candesartan daily dose was 24mg at 6 months.Candesartan reduced the primary endpoint of cardiovascular death or heart failure hospitalizations (37.9% vs 42.3%, adjusted HR: 0.85, 95% CI: 0.75 – 0.96; p= 0.01). Candesartan reduced the individual components of the primary outcome - (23.7% vs 27.3%; p= 0.021) for cardiovascular death and (24.2% vs 28.0%; p= 0.018) for heart failure hospitalizations. There was no significant reduction in all-cause death (29.5% with candesartan vs 32.4%; p= 0.105). The number of patients who had any hospitalization was similar in both groups (66.8% with candesartan vs 67.5%; p= 0.7), however, the total number of hospitalizations was lower with candesartan (2,462 vs 2,798; p= 0.023).Serum creatinine at least doubled in 7% of the patients in the candesartan group vs 6% in the placebo group. In the subset of patients taking spironolactone, serum creatinine at least double in 11% of the patients taking candesartan compared to 4% of the patients taking placebo.Hyperkalemia, defined as serum potassium of 6 mmol/L or higher, occurred in 3% of the patients in the candesartan group vs 1% in the placebo group. In the subset of patients taking spironolactone, hyperkalemia occurred in 4% of the patients taking candesartan compared to 1% of the patients taking placebo.There were two cases of angioedema in the candesartan group and three in the placebo group. All patients were taking an ACEi.There were no significant subgroup interactions, including in patients taking both beta-blockers and ACEi at baseline.Conclusion: In patients with systolic heart failure, adding candesartan to an ACEi reduced the primary composite outcome of cardiovascular death or heart failure hospitalizations with a number needed to treat of approximately of 23 patients over 41 months of follow up. The total number of all-cause hospitalizations was reduced by 336 with candesartan. All-cause death was not significantly reduced with candesartan.While the results of the trial appear impressive, the high number of adverse outcomes with candesartan in patients taking spironolactone is concerning. Spironolactone led to significant reduction in all-cause mortality in patients with systolic heart failure, as seen in the RALES trial, and should be prioritized over adding candesartan. Notably, fewer than 20% of patients in the trial were on spironolactone at baseline; if more had been, the incremental benefit of candesartan would likely have been reduced due to an increased risk of adverse effects from triple neurohormonal blockade (ACEi, ARBs, and mineralocorticoid receptor antagonists). Furthermore, spironolactone acts by blocking the aldosterone receptor, which is downstream in the renin–angiotensin–aldosterone system. Since candesartan blocks angiotensin II upstream in the same pathway, simultaneous inhibition at multiple points may lead to diminishing benefit.Finally, the differences observed in the subgroup of patients on beta-blockers between this trial and Val-HeFT remain unclear and may simply reflect the play of chance. As we previously discussed, patients receiving both an ACEi and beta-blockers had worse outcomes with valsartan in the Val-HeFT trial.Cardiology Trial's Substack is a reader-supported publication. To receive new posts and support our work, consider becoming a free or paid subscriber. Get full access to Cardiology Trial's Substack at cardiologytrials.substack.com/subscribe

Pip reviews Prairie, Dresses, Art, Other by Danielle Dutton (Coffee House Press), American Precariat: Parable of Exclusion by Zeke Caligiuri (Coffee House Press) and Sound Museum by Poupeh Massaghi (Coffee House Press).

We're talking this month about Building a Bigger Tent at our farmers markets. Let's remember that the more people and communities we welcome to markets, the deeper our variety of produce, products and personalities. Exclusion, whether purposeful or just thoughtless, means we miss out on all the richness that comes with diversity.   Sagdrina Brown Jalal is back with us for this episode, just in time for Juneteenth. While that day of historic remembrance is coming up next week on June 19th, observances and events will start this weekend and extend into next. We're talking about how your market can support that holiday. And we're looking at how organizations like the West Georgia Farmers Cooperative are working to level the playing field and lift up small farmers all year round. Tune in while we discuss:   Support can be more appropriate than leadership The exhausting history of resilience Bridging urban and rural division Looking beyond Federal funding Partnership and collaboration as strength #Farmersmarkets #Juneteenth #Blackfarmersmarkets #Cooperatives #Belovedcommunity #SageDCollective

Join our next weekly live parent events:  https://smartsocial.com/eventsWhat does online exclusion really feel like for kids—and how can parents and educators help?In this Josh Talk, we explore the emotional impact of being left out online. Whether it's being ghosted in a group chat or seeing a party they weren't invited to, these digital moments can affect a child's self-esteem.Josh shares practical ways to:Recognize when your child is quietly hurtingReframe online rejection and model healthy copingStrengthen offline relationships to build confidenceTune in to learn how to support students through the ups and downs of digital life.Become a Smart Social VIP (Very Informed Parents) Member: https://SmartSocial.com/vipDistrict Leaders: Schedule a free phone consultation to get ideas on how to protect your students in your community https://smartsocial.com/partnerDownload the free Smart Social app: https://www.smartsocial.com/appdownloadLearn about the top 190+ popular teen apps: https://smartsocial.com/app-guide-parents-teachers/View the top parental control software: https://smartsocial.com/parental-control-software/The SmartSocial.com Podcast helps parents and educators to keep their kids safe on social media, so they can Shine Online™

Ambition is the air we breathe—but what is it costing us? In this episode, Amy Julia Becker and theologian Miroslav Volf discuss his latest book, The Cost of Ambition. They unpack the hidden damage of a culture obsessed with competition and invite us to imagine a new way of being, for ourselves and our society, rooted not in achievement, but in love, mutuality, and genuine abundance. They explore:  Striving for superiority in American cultureThe dark side of competitionLonging for what we haveStriving for excellence vs. striving for superiorityThe illusion of individual achievementPractices for embracing love and generosityReimagining human relationships beyond superiority__MENTIONED IN THIS EPISODE:The Cost of Ambition: How Striving to Be Better Than Others Makes Us Worse by Miroslav VolfAbundance by Ezra KleinThe Sabbath by Abraham HeschelLuke 18:9-14, Philippians 2, 1 Corinthians 12:21-26, Mark 10:35-45The Magnificat (Luke 1:46-55)Works of Love by Søren KierkegaardSubscribe to Amy Julia's newsletter_WATCH this conversation on YouTube by clicking here. READ the full transcript and access detailed show notes by clicking here or visiting amyjuliabecker.com/podcast._ABOUT:Miroslav Volf (DrTheol, University of Tübingen) is the Henry B. Wright Professor of Theology at Yale Divinity School and founding director of the Yale Center for Faith and Culture in New Haven, Connecticut. He has written or edited more than two dozen books, including the New York Times bestseller Life Worth Living, A Public Faith, Public Faith in Action, and Exclusion and Embrace (winner of the Grawemeyer Award in Religion and selected as among the 100 best religious books of the 20th century by Christianity Today). Educated in his native Croatia, the United States, and Germany, Volf regularly lectures around the world. CONNECT with Miroslav Volf on X at @miroslavvolf.Photo Credit: © Christopher Capozziello___Let's stay in touch. Subscribe to my newsletter to receive weekly reflections that challenge assumptions about the good life, proclaim the inherent belovedness of every human being, and envision a world of belonging where everyone matters.We want to hear your thoughts. Send us a text!Connect with me: Instagram Facebook YouTube Website Thanks for listening!

Join Charna Parkey as she welcomes Anastasia Stasenko, CEO and co-founder of pleias, through her unique journey from philosophy to building open-source, energy-efficient LLMs. Discover how pleias is revolutionizing the AI landscape by training models exclusively on open data and establishing a precedent for ethical and socially acceptable AI. Learn about the challenges and opportunities in creating multilingual models and contributing back to the open-source community. QUOTES[00:00:00] Introducing Anastasia and pleias[00:02:00] From Philosophy to AI[00:06:00] The Problem of Generic Models[00:10:00] Open Weights vs. Open Source vs. Open Science[00:14:00] Why Open Data Matters[00:18:00] High-Quality, Specialized Models[00:22:00] Multilingual Challenges[00:26:00] Global Inclusion Requires Small Models[00:30:00] Using and Contributing to Wikidata[00:38:00] The Future: Specialized Models[00:48:00] Advice for Newcomers[00:54:00] Cultural Sensitivity and Data Representation[00:50:00] Leo's Takeaways[00:52:00] Charna on Ethical, Verifiable AI[00:54:00] Representation vs. Exclusion[00:56:00] Letting People Be More Human[00:57:30] Applied, Transformative AIQUOTESCharna:"If you didn't make it represented in the data, then we're leaving another culture behind... So which one are you wanting to do, misrepresent them or just completely leave them behind from this technical revolution?"Anastasia:"The real issue now is that the lack of diversity in the current AI labs leads to the situation where all LLMs look alike."Anastasia:"Being able to design, to find, and also to create the appropriate data mix for large language models is something that we shouldn't really forget about when we talk about the success of what large language models are."

6.2.25, Eric Edholm from NFL Network joins Denton Day to break down the Commanders roster and what went into his NFL roster ranking list.

Did you know there's a way to get tax-free income, tax-free growth, AND tax-free withdrawals—all legally? If you're in the military, you have access to one of the most powerful wealth-building tools that civilians can only dream of. Combat Zone Tax Exclusion (CZTE) is the golden ticket, and in this episode, we break down exactly how you can leverage it to maximize your savings and accelerate your journey to financial freedom. Episode Summary: Military members deployed to a Combat Zone Tax Exclusion (CZTE) location receive tax-free pay, but did you know this can also supercharge your retirement savings?  No federal income tax on military pay earned in a combat zone. Contributions to Roth IRA or Roth TSP using tax-exempt combat pay grow tax-free. Withdrawals in retirement are completely tax-free, giving you a massive financial advantage. We also discuss the Savings Deposit Program (SDP), tips for avoiding common financial mistakes, and strategies to maximize your tax-free earnings while deployed. Key Takeaways: Maximize Your Benefits: Understand the triple tax benefits and how to supercharge your Roth TSP and Roth IRA. Combat Zone Pay Benefits: Know which locations qualify and how even touching a combat zone for one day can get you CZTE benefits. Emergency Fund First: Use the extra tax-free income to build financial security before investing. Savings Deposit Program (SDP): Earn a guaranteed 10% return with this little-known military savings program. Tax Planning Strategies: Advanced moves like Roth conversions, tax-gain harvesting, and earned income tax credit eligibility. Watch Out for Common Mistakes: Avoid lifestyle inflation and missed opportunities to grow tax-free wealth. Links mentioned today: IRS Publication 3, Armed Forces Tax Guide IRS.gov CZTE locations (as of this publishing) DFAS.mil's Imminent Danger Pay (IDP) info Savings Deposit Program (SDP) Article Responding to CP04 IRS Letter Article Military Tax Experts Alliance Episode 167 w/ Ryan Guina, Contributing up to $70,000 to TSP while Deployed! Episode 116 - Roth TSP and Roth IRA are Different!! For a limited time, Spencer is offering one-on-one Military Money Mentor sessions! Get your personal military money and investing questions answered in a confidential coaching call. Our new TSP course is live! Check out the Confident TSP Investing course at militarymoneymanual.com/tsp to learn all about the Thrift Savings Plan and strategies for growing your wealth while in the military. Use promo code "podcast24" for $50 off. Plus, for every course sold, we'll donate one course to an E-4 or below- for FREE! If you have a question you would like us to answer on the podcast, please reach out on instagram.com/militarymoneymanual or email podcast@militarymoneymanual.com. If you want to maximize your military paycheck, check out Spencer's 5 star rated book The Military Money Manual: A Practical Guide to Financial Freedom on Amazon or at shop.militarymoneymanual.com. I also offer a 100% free course on military travel hacking and getting annual fee waived credit cards, like The Platinum Card® from American Express, the American Express® Gold Card, and the Chase Sapphire Reserve® Card in my Ultimate Military Credit Cards Course at militarymoneymanual.com/umc3. Learn how to get your annual fees waived on premium credit cards from American Express in the Ultimate Military Credit Cards Course at militarymoneymanual.com/umc3. The Platinum Card® from American Express and the American Express® Gold Card waive the annual fee for active duty military servicemembers, including Guard and Reserve on active orders over 30 days. The annual fees on all personal Amex cards are also waived for military spouses married to active duty troops.

Section 301 tariff exclusions due to expire on 5/31 were extended at the last minute until 8/31. Listen for more on Two Minutes in Trade. 

What does it mean to truly belong in America?  Michael Luo, executive editor at The New Yorker and author of Strangers in the Land, joins Redeeming Babel's director of content, DT Slouffman, to explore the Asian American experience—from the legacy of the Chinese Exclusion Act to the rise in anti-Asian hate during the COVID-19 pandemic. Drawing from personal stories and a viral moment that sparked national conversation, Luo confronts the “perpetual foreigner” stereotype and envisions a more inclusive vision of American identity. DT and Michael unpack how race, immigration, and belonging continue to shape all of our lives. Send written questions or voice memos for “Ask Curtis” episodes to: askcurtis@redeemingbabel.org Send Campfire Stories to: info@redeemingbabel.org   Resources mentioned in this episode: Michael Luo's An Open Letter to the Woman Who Told My Family to Go Back to China Kirkus Reviews: A Vast History Began With One Sidewalk Encounter  Chinese Exclusion Act, 1882 The Burlingame-Seward Treaty, 1868 Immigration and Nationality Act, 1965 Pew Research: Asian American discrimination in the COVID-19 pandemic Pew Research: A third of Asian Americans changed daily routine due to threats   More From Michael Luo: Michael Luo's Strangers in the Land: Exclusion, Belonging, and the Epic Story of the Chinese in America  Michael Luo's latest articles at The New Yorker Follow Michael Luo on Instagram Follow Michael Luo on X (formerly Twitter)   Follow Us: Good Faith on Instagram Good Faith on X (formerly Twitter) Good Faith on Facebook   Sign up: Redeeming Babel Newsletter

At the heart of Dr. Erik Carter's Main Stage talk at Disability and the Church Conference 2025, lies a compelling vision: a church where everyone — no asterisks, no exceptions — is welcomed, valued, and needed. His message to ministry leaders and congregations is both a challenge and an encouragement: shift from passive welcome to active inclusion, especially for families impacted by disability.Find the full show-notes at: www.keyministry.org/podcast/

AP correspondent Charles de Ledesma reports Chinese university students in Beijing are concerned over the future of student exchange programs, after Secretary of State Marco Rubio said some Chinese students would have their U.S. visas revoked.

Listen as Michael S. Blaiss, MD provides case-based perspectives on chronic cough recognition, burden, management, and pathophysiology and describes the evolving treatment landscape for refractory chronic cough.PresenterMichael S. Blaiss, MDClinical Professor of PediatricsDivision of Allergy-ImmunologyMedical College of Georgia at Augusta UniversityAugusta, GeorgiaLink to full program: https://bit.ly/4kweynG

Inclusion, Exclusion, Agency, and Advocacy: Experiences of Women With Physical Disabilities in China, With Worldwide Implications (IAP, 2024) explores the lived experiences of six women, including the author herself, with physical disabilities in China. The book provides in-depth descriptions of each woman's experiences in different aspects and analyze the commonalities and differences in their experiences through their life courses. The book explores answers to some of these questions: How do physically disabled women make sense of their experiences? What are some of the empowering and/or disempowering moments/events in their lives, if any? What are disabled women's experiences in terms of education, employment, relationships, family life, and social activism? How does some of the disabled women in the book become motivated and mobilized to work on disability issues? This book serves to amplify Chinese disabled women's stories and make their presence more visible. Too often, dominant narratives and depictions of disability are written by people without disabilities, while disabled people's voices are either invisible or secondary. Sadly, this phenomenon is not new and disability advocates have been faced with these types of narratives for quite some years. To have one's own voice and speak up is to claim subjectivity, agency, and power. Different stories told by women with disabilities themselves can enrich our understanding of disability and gender. These stories have the potential to challenge dominant and oppressive narratives prevalent in our ableist societies. The stories included in this book could provide space and potential to connect with disabled people (people with either visible or invisible disabilities) elsewhere. Women's empowering experiences and encounters shown in this book could inspire relevant stakeholders to think of ways to better understand and support disabled women in their environments. This book will have wide implications for readers not only in China, but also in other parts of the world. Many disability stories of exclusion and/or empowerment of the world are still hidden and not reflected upon. The author invites readers to reflect on their own experiences and how societies have impacted the life courses of individuals with or without disabilities in their respective social, political, economic, and cultural environments. Cultural and social change around disability can start with anyone who are touched by genuine stories of vulnerability and reflexivity, as the ones to be shared in this book. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/gender-studies

Dive deep into the complexities of faith, identity, and personal growth in this transformative episode of "The Midlife Revolution." In this episode, I explore my journey of leaving the Mormon Church after decades of membership, focusing on a significant talk by Elder Dallin H. Oaks from October 2019. This discussion centers on his views on women's roles and the church's stance towards the LGBTQ community, highlighting the gap between the church's inclusive rhetoric and its exclusionary policies.Listen as I dissect the implications of these teachings on personal lives, especially for women over 40 who are reevaluating their faith and seeking authenticity in their spiritual journey.Learn how small, positive changes can lead to profound life improvements, using my own experience as a testament to the power of personal revolution at midlife.Explore the dissonance between 'all are welcome' statements and the reality of church policies that bar full participation for the LGBTQ community.This episode is not just about critique; it's a beacon for those navigating their way out of high control environments, whether religious, familial, or otherwise. Join the conversation on:Finding your voice after years of silenceRebuilding your life with authenticity and joy Embracing change in midlife Leaving Mormon Church, high control religions, women over 40, Dallin H. Oaks, LDS Church critique, faith deconstruction, personal growth, midlife change, small positive changes, LGBTQ exclusion, spiritual awakening, authenticity in faith, leaving religion, life after church, women's roles in church. #MidlifeRevolution #FaithDeconstruction #HighControlReligionSubscribe to "The Midlife Revolution" for more stories of transformation, empowerment, and finding your path in midlife. Click the bell icon to get notified about new videos that might just change your life's trajectory. Join our community of brave souls choosing to live their truth, one step at a time.

Inclusion, Exclusion, Agency, and Advocacy: Experiences of Women With Physical Disabilities in China, With Worldwide Implications (IAP, 2024) explores the lived experiences of six women, including the author herself, with physical disabilities in China. The book provides in-depth descriptions of each woman's experiences in different aspects and analyze the commonalities and differences in their experiences through their life courses. The book explores answers to some of these questions: How do physically disabled women make sense of their experiences? What are some of the empowering and/or disempowering moments/events in their lives, if any? What are disabled women's experiences in terms of education, employment, relationships, family life, and social activism? How does some of the disabled women in the book become motivated and mobilized to work on disability issues? This book serves to amplify Chinese disabled women's stories and make their presence more visible. Too often, dominant narratives and depictions of disability are written by people without disabilities, while disabled people's voices are either invisible or secondary. Sadly, this phenomenon is not new and disability advocates have been faced with these types of narratives for quite some years. To have one's own voice and speak up is to claim subjectivity, agency, and power. Different stories told by women with disabilities themselves can enrich our understanding of disability and gender. These stories have the potential to challenge dominant and oppressive narratives prevalent in our ableist societies. The stories included in this book could provide space and potential to connect with disabled people (people with either visible or invisible disabilities) elsewhere. Women's empowering experiences and encounters shown in this book could inspire relevant stakeholders to think of ways to better understand and support disabled women in their environments. This book will have wide implications for readers not only in China, but also in other parts of the world. Many disability stories of exclusion and/or empowerment of the world are still hidden and not reflected upon. The author invites readers to reflect on their own experiences and how societies have impacted the life courses of individuals with or without disabilities in their respective social, political, economic, and cultural environments. Cultural and social change around disability can start with anyone who are touched by genuine stories of vulnerability and reflexivity, as the ones to be shared in this book. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

Inclusion, Exclusion, Agency, and Advocacy: Experiences of Women With Physical Disabilities in China, With Worldwide Implications (IAP, 2024) explores the lived experiences of six women, including the author herself, with physical disabilities in China. The book provides in-depth descriptions of each woman's experiences in different aspects and analyze the commonalities and differences in their experiences through their life courses. The book explores answers to some of these questions: How do physically disabled women make sense of their experiences? What are some of the empowering and/or disempowering moments/events in their lives, if any? What are disabled women's experiences in terms of education, employment, relationships, family life, and social activism? How does some of the disabled women in the book become motivated and mobilized to work on disability issues? This book serves to amplify Chinese disabled women's stories and make their presence more visible. Too often, dominant narratives and depictions of disability are written by people without disabilities, while disabled people's voices are either invisible or secondary. Sadly, this phenomenon is not new and disability advocates have been faced with these types of narratives for quite some years. To have one's own voice and speak up is to claim subjectivity, agency, and power. Different stories told by women with disabilities themselves can enrich our understanding of disability and gender. These stories have the potential to challenge dominant and oppressive narratives prevalent in our ableist societies. The stories included in this book could provide space and potential to connect with disabled people (people with either visible or invisible disabilities) elsewhere. Women's empowering experiences and encounters shown in this book could inspire relevant stakeholders to think of ways to better understand and support disabled women in their environments. This book will have wide implications for readers not only in China, but also in other parts of the world. Many disability stories of exclusion and/or empowerment of the world are still hidden and not reflected upon. The author invites readers to reflect on their own experiences and how societies have impacted the life courses of individuals with or without disabilities in their respective social, political, economic, and cultural environments. Cultural and social change around disability can start with anyone who are touched by genuine stories of vulnerability and reflexivity, as the ones to be shared in this book. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/east-asian-studies

Inclusion, Exclusion, Agency, and Advocacy: Experiences of Women With Physical Disabilities in China, With Worldwide Implications (IAP, 2024) explores the lived experiences of six women, including the author herself, with physical disabilities in China. The book provides in-depth descriptions of each woman's experiences in different aspects and analyze the commonalities and differences in their experiences through their life courses. The book explores answers to some of these questions: How do physically disabled women make sense of their experiences? What are some of the empowering and/or disempowering moments/events in their lives, if any? What are disabled women's experiences in terms of education, employment, relationships, family life, and social activism? How does some of the disabled women in the book become motivated and mobilized to work on disability issues? This book serves to amplify Chinese disabled women's stories and make their presence more visible. Too often, dominant narratives and depictions of disability are written by people without disabilities, while disabled people's voices are either invisible or secondary. Sadly, this phenomenon is not new and disability advocates have been faced with these types of narratives for quite some years. To have one's own voice and speak up is to claim subjectivity, agency, and power. Different stories told by women with disabilities themselves can enrich our understanding of disability and gender. These stories have the potential to challenge dominant and oppressive narratives prevalent in our ableist societies. The stories included in this book could provide space and potential to connect with disabled people (people with either visible or invisible disabilities) elsewhere. Women's empowering experiences and encounters shown in this book could inspire relevant stakeholders to think of ways to better understand and support disabled women in their environments. This book will have wide implications for readers not only in China, but also in other parts of the world. Many disability stories of exclusion and/or empowerment of the world are still hidden and not reflected upon. The author invites readers to reflect on their own experiences and how societies have impacted the life courses of individuals with or without disabilities in their respective social, political, economic, and cultural environments. Cultural and social change around disability can start with anyone who are touched by genuine stories of vulnerability and reflexivity, as the ones to be shared in this book. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/chinese-studies

In this episode we welcome Sarah Bryant, Finger Lakes Program Manager, and Isabel Barbosa, Special Population Coordinator. They join us to discuss the Voluntary Self-Exclusion program and supportive services. Questions that are discussed include:What is Voluntary Self-Exclusion (VSE)?What is the process to complete the VSE form?How can we connect with help to complete the VSE form?How does the VSE program work with casinos and benefit them?How does the VSE help make the casino environment better?How is an empathetic approach a beneficial strategy?Is there something we're doing with the casinos that can help them?Do we have a training that is specific to casino employees?Can someone refer themselves or someone else for VSE?Who do you contact to access this information and support? If you find yourself struggling with gambling harm, or if you suspect someone you know is facing such challenges, don't hesitate to seek help. For 24/7 support, call the NYS OASAS HOPEline at 1-877-846-7369 or text 467369. Or choose your county using our interactive map on our NYProblemGamblingHELP.org HOME PAGE to see the contact information for the Problem Gambling Resource Center (PGRC) in your region.

Most of us can remember those pit-in-the-stomach times we experienced as teenagers when we realized we had been left out. I remember a summer day in the neighborhood when I couldn't find any of my friends at home. I couldn't figure out why they were all gone until somebody spilled the beans later, telling me that they had all been invited to go to a home in another neighborhood to swim in the families' pool. Truth be told, I felt like a loser. The journal Frontiers in Digital Health reports that for kids living in today's social media world, the feelings I felt on that one summer day occur far more frequently, as our kids see visual and story content recounting activities and gatherings of friends from which they've been excluded. This ramps up feelings of exclusion, jealousy, and rejection. Researchers say this is feeding emotional stress and creating interpersonal conflict. Let's use these moments to teach our kids to handle disappointment and conflict with the kindness and grace of Jesus Christ. 

If you're going to grow you need to get rid of those negative habits, negative beliefs, etc—right?? NOPE. Do this instead and you'll grow much faster.

N Engl J Med 1996;334:1349-1355Background Before 1990, the prevailing idea held that the negative inotropy of beta-blockers would harm patients with impaired systolic function. Yet part of the progression of systolic heart failure involved over stimulation of the sympathetic nervous system. Norepinephrine can exert adverse effects on the circulation, both directly and indirectly. Smaller trials of beta-blockers in systolic heart failure found trends for benefit with beta-blockers, however, a mortality benefit had not yet been proven. The U.S. Carvedilol Heart Failure Study aimed to study mortality in patients with heart failure with a reduced ejection fraction.Cardiology Trial's Substack remains free of industry ads because of your support. Thank you. Please consider becoming a free or paid subscriber.Patients The study enrolled 1094 patients with chronic heart failure symptoms for at least 3 months, LVEF ≤ 0.35%, at least 2 months of treatment with diuretics and an angiotensin-converting enzyme (ACE) inhibitor (if tolerated). Treatment with digoxin, hydralazine, or nitrates was permitted but not required.Exclusion criteria were extensive and important to understand. These included any recent major cardiac events or surgery within the previous 3 months, uncorrected valvular disease, active myocarditis, sustained VT or higher degrees of AV block not controlled by pacing, systolic blood pressure of more than 160 or less than 85 mm Hg or diastolic blood pressure of more than 100 mm Hg, clinically significant kidney or liver disease or use of calcium-channel blockers, adrenergic agonists/antagonists, or class IC/III antiarrhythmic agents. Patients receiving β-adrenergic agonists or antagonists (presumably for another indication) were not enrolled.Baseline Characteristics The results of this and other beta-blocker trials in heart failure will be clear. One of the most important points for translating this evidence to patients will be the baseline characteristics. It is vital to understand who these patients were.The mean age was 58 years and approximately 76% were male. Most patients had mild to moderate heart failure, with 53% in NYHA Class II, 44% in Class III, and only 3% in Class IV. The etiology of heart failure was nearly evenly split between coronary artery disease (47%) and nonischemic cardiomyopathy (53%). Patients had significantly impaired cardiac function with a mean LVEF of 0.23. The mean six-minute walk distance ranged from 386 to 390 meters. Hemodynamic parameters were relatively stable, with mean systolic blood pressure of 116 mmHg, and mean heart rate of 83-84 beats per minute. Most patients were receiving standard heart failure therapy at baseline, including digitalis (90-91%), loop diuretics (95%), and ACE inhibitors (95%), while approximately one-third (32%) were on direct-acting vasodilators.Trial Procedures Patients were assessed for eligibility during a 3-week screening period during which exercise capacity was assessed with a 6-minute walk test. Notable was that these were outpatients able to complete a 6-minute walk test. Enrollment was stratified to one of four treatment protocols on the basis of the patients' performance on the exercise test: patients able to walk between 426 and 550 m when tested were assigned to the mild-heart-failure protocol; those able to walk between 150 and 425 m were assigned either to the moderate-heart-failure protocol or to a dose-ranging protocol, depending on the location of the study center; and those able to walk only less than 150 m were assigned to the severe-heart-failure protocol.After this base-line testing, all patients received 6.25mg of carvedilol twice daily for two weeks in an open-label run-in period. Those who tolerated this initial dose were then randomized to receive either placebo (n=398) or carvedilol (n=696) on a double-blind basis, in addition to their usual medications.The allocation ratio (carvedilol:placebo) was 2:1 in the mild and severe heart failure protocols and 1:1 in the moderate heart failure protocol. The dose was gradually increased to target levels of 25-50mg twice daily over 2-10 weeks, followed by maintenance therapy for an additional 6 months (12 months for mild heart failure).Endpoints At the time of trial planning, the original intent was safety. That is, to show that carvedilol did not increase mortality. The original intent was to enroll 1100 patients. As smaller trials on beta-blockers were published, the statistical plan included the possibility of beta-blocker benefit. The trialists therefore planned two sided statistical analysis.Cumulative survival curves were constructed as time-to-first-event plots by Kaplan–Meier survivorship methods and differences between the curves were tested for significance by the log-rank statistic with use of a Cox proportional-hazards regression model (which included the protocol as a covariate).Results Median follow-up was only 6.5 months due to early termination for benefit. The patients mean total daily dose of carvedilol was 45±27 mg. Overall mortality was 7.8% in the placebo group vs. 3.2% in carvedilol group. The relative risk reduction from carvedilol vs placebo was 65% (95% CI, 39-80%; p

The Eikon team explores the differences between bounded and centered gospels, discussing the implications of church dynamics on inclusion and exclusion. They delve into the nature of bounded churches, the judgmentalism that can arise, and the importance of fostering a community that encourages exploration of faith. The discussion highlights the spectrum of church mentalities, the impact of exclusion on individual identity, and the need for a more inclusive approach that focuses on unity rather than uniformity.   00:00 Introduction to Bounded and Centered Set Gospels09:13 Exploring the Concept of Bounded vs. Centered Gospels19:09 Real-World Applications and Implications of Gospel Types29:15 Navigating Boundaries in Faith Communities31:42 Understanding Bounded vs. Centered Gospels36:47 The Nature of Bounded Churches40:33 The Role of Judgmentalism in Bounded Groups45:06 Exploring Inclusion and Exclusion48:33 Unity vs. Uniformity in Church Dynamics52:35 The Spectrum of Church Mentalities57:05 The Impact of Exclusion on Individual Identity01:01:39 Navigating Personal Beliefs in Church Contexts01:08:35 Looking Ahead: Centered Gospels

Goods qualifying under the Nairobi Protocol (subheadings 9817.00.92-96) are exempt from MFN duties, but also from Section 301 and IEEPA duties.  Here, we provide a high-level review of the qualification requirements.

Winning a jury bias argument typically involves demonstrating that the jury selection process was flawed in a way that unfairly prejudiced the jury against the defendant. Here are some factors that defense lawyers might consider and try to establish to win a jury bias argument:Prejudicial Statements or Behavior: If potential jurors made prejudicial statements during voir dire (the process of jury selection) or exhibited behavior indicating bias, the defense attorney could argue that these jurors should have been dismissed for cause but were not.Media Exposure: If there was extensive media coverage of the case that may have biased the jury, the defense attorney might argue that the jurors were unable to set aside preconceived notions and render an impartial verdict.Improper Questioning by Prosecution: If the prosecution's questioning during voir dire was leading or unfairly suggestive, the defense attorney could argue that this influenced the jury pool's perception and led to bias against the defendant.Exclusion of Potentially Favorable Jurors: If the judge excluded potential jurors who might have been sympathetic to the defense or who had relevant life experiences that could have helped them better understand the case, the defense attorney might argue that this biased the jury against the defendant.Inadequate Voir Dire Examination: If the defense attorney believes that the voir dire examination of potential jurors was inadequate and failed to uncover biases or prejudices, they could argue that this resulted in an unfair jury.Pattern of Exclusions: If there's evidence to suggest a pattern of excluding certain demographic groups or individuals with particular characteristics from the jury, the defense attorney might argue that this systematic exclusion led to a biased jury.Judicial Error: If the judge made errors during jury selection or failed to adequately address concerns raised by the defense about potential biases, the defense attorney could argue that these judicial errors resulted in a biased jury.Ineffective Assistance of Counsel: In extreme cases where the defense attorney's performance during jury selection was deficient and resulted in a biased jury, the defendant might argue that they did not receive effective assistance of counsel, which violated their constitutional rights.To win a jury bias argument, the defense attorney would need to present evidence and arguments demonstrating one or more of these factors and persuade the judge that the defendant's right to a fair trial was compromised.Anne Taylor, the lawyer for Bryan Kohberger, continues to try to pull a rabbit out of her hat for her client by attacking the processs itself and looking for any loophole or technicality that might help Kohberger skate.   Unfortunately for Kohberger, all of those attempts have been slapped back by the court.   In this episode, we take a look at the newest claim made by Anne Taylor and this time it has to do with jury bias.(commercial at 6:51)to contact me:bobbycapucci@protonmail.comsource:Bryan Kohberger's Attorney Discovers Troubling Sign for Trial (newsweek.com)

The institution of slavery permeated the ancient world, such that the realities of slavery and its long shadows pervade the New Testament and other early Christian texts. Yet enslavement remains an under-taught aspect of the context of the New Testament and early Christianity, leaving pastors, laypersons, and neophyte college students alike to fill knowledge gaps about enslaved persons, enslavers, living and laboring conditions, and much more with partial information, assumptions, or a range of highly technical and specialized monographs.  Ancient Slavery and Its New Testament Contexts (Eerdmans, 2025), co-edited by Christy Cobb and Katherine A. Shaner, takes on these issues, introducing readers to the textures, complexities, and material realities of slavery in the Greco-Roman world. International scholars with a range of expertise, from New Testament and early Christian studies to classics, theology, ethics, and more, contribute to a tapestry of introductory themes, topics, and interpretive frameworks with a wealth of literary, inscriptional, pictorial, and theoretical evidence from the material culture of Roman antiquity in this significant volume. Dr. Cobb and Dr. Shaner joined the New Books Network to initiate important conversations that they hope will continue in religious studies classrooms, schools of theology and divinity, and local church small group settings. Christy Cobb (Ph.D., Drew University, 2016) is Associate Professor of Christianity at the University of Denver. She is the author of Slavery, Gender, Truth and Power in Luke-Acts and Other Ancient Narratives (Palgrave Macmillan, 2019) and has also co-edited a volume entitled Sex, Violence, and Early Christian Texts (Lexington Books, 2022). Dr. Cobb is also a member of the editorial board for the Journal of Feminist Studies in Religion, and her research and teaching interests include slavery, gender, sexuality, Acts, and Apocryphal Acts. In her recreational time, Christy enjoys reading novels, crafts, and spending time with her nine-year-old son in Denver. Katherine A. Shaner (Th.D., Harvard University Divinity School, 2012) is Associate Professor of New Testament at the Wake Forest University School of Divinity. She is the author of Enslaved Leadership in Early Christianity (Oxford University Press, 2018) as well as numerous articles on slavery in the New Testament. Dr. Shaner is an ordained pastor in the Evangelical Lutheran Church in America (ELCA) and regularly preaches and teaches in churches around the United States. In her free time, Katherine enjoys hiking in the mountains, reading historical fiction, cooking dinner for friends and spending time with snuggly dogs. Rob Heaton (Ph.D., University of Denver, 2019) hosts Biblical Studies conversations for New Books in Religion and teaches New Testament, Christian origins, and early Christianity at Anderson University in Indiana. He recently authored The Shepherd of Hermas as Scriptura Non Grata: From Popularity in Early Christianity to Exclusion from the New Testament Canon (Lexington Books, 2023). For more about Rob and his work, or to offer feedback related to this episode, please visit his website at https://www.robheaton.com. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

In this episode, Rooster and Joe return from a year-long podcast break and are joined by Amanda Turner, a witty and insightful advocate living with a disability. Amanda shares stories from her vacation, her journey from being pushed in races to racing independently, and her humorous approach to advocacy. She emphasizes the importance of inclusive humor, planning for long-term care, and building two-way bridges between disabled and non-disabled communities. Audio version of the Together, We Shall Podcast can be found on Buzzsprout (link below), on the Apple Podcast app, as well as on Spotify, Amazon, and the Ainsley's Angels YouTube channel for those seeking closed captioning or just like to watch vice listen to podcasts. https://twspodcast.buzzsprout.com Together, We Shall Podcast is hosted by Kim ‘Rooster' Rossiter, President and Co-Founder of Ainsley's Angels of America, and Joe Orth, Executive Vice President of Ainsley's Angels. This inclusive podcast takes you into a world of tangents and thoroughfares, focusing on a conversation to be determined. Highlighting current events, insightful antidotes and life lessons with banter, sit back and listen to a little bit of humor and a few emotional deep dives during each episode. Let's roll! If you would like to join us on the podcast, place to share/tell stories and connect, or nominate someone to join us on the podcast, email us at Podcast@AinsleysAngels.org

After suffering complications during the birth of her son, Leo, in 2021, former Made in Chelsea star Louise Thompson developed PTSD. She posted about this to her followers on social media and has now written about it in her new book, Lucky. She told Clare McDonnell about her experience and why she is trying to break the taboo surrounding birth trauma.People who have committed murder, manslaughter or stalking offences should be forced to live in restricted areas after being released from prison on licence, according to a group of campaigners. BBC journalist Gemma Dunstan and law-change campaigners Rhianon Bragg and Dianna Parkes join Anita Rani to discuss. The Prime Minister Keir Starmer has welcomed the UK Supreme Court decision on the legal definition of a woman. His office has confirmed that he no longer believes trans women are women. There have been protests against the decision, with critics saying it is incredibly worrying for the trans community. The ruling followed a long-running legal battle between the Scottish Government and the campaign group For Women Scotland. Susan Smith, one of the directors, spoke to Clare and gave her reflections on the outcome, a week on.TV presenter, writer and self-declared 'homes therapist' Michelle Ogundehin joined Nuala to talk about decluttering and the connection between our home and our wellbeing, her personal wardrobe strategy and her love of curated things that tell our story.Emma-Jean Thackray is a multi-instrumentalist, singer, producer, bandleader and DJ. Her sound has incorporated the widest range of music, from jazz and funk to Detroit house and techno, northern Bassline and catchy rock and pop music. She joined Anita to discuss her new album Weirdo and the inspiration behind it. Presenter: Anita Rani Producer: Dianne McGregor

This morning, the UK regulator Ofcom released its Children's Safety Codes. These are the regulations that platforms will have to follow to protect young users and abide by the Online Safety Act. Platforms will have three months to carry out a risk assessment and bring the codes into effect. Ofcom can start enforcing the regulations from July. The most significant aspect is the requirement for strong age verification. Anita Rani hears from Baroness Beeban Kidron, founder of Five Rights, an international NGO working with and for children for a rights-respecting digital world, and Ian Russell, Chair of the Molly Rose Foundation. Ian's daughter Molly took her life at the age of 14 after being exposed to harmful content online.A new report says 91% of organisations in the UK's women and girls sector have seen a rise in demand for their services, but only 52% expect to be able to meet it. The report - from Rosa, the UK fund for women and girls - also found that 1.8% of charitable giving goes to women's charities although they represent at least 3.5% of charities. Anita is joined by Rebecca Gill, Executive Director at Rosa UK fund for women and girls and Cecily Mwaniki, Director of Utulivu, who support Black, Asian, Minority Ethnic and refugee women, girls, and their families in Reading.According to campaigners, people who have committed murder, manslaughter or stalking offences should be forced to live in restricted areas after being released from prison on licence. Anita is joined by BBC journalist Gemma Dunstan and law-change campaigners Rhianon Bragg and Dianna Parkes. 29-year-old Pippa White shares her daily life as a vicar to millions of viewers on TikTok. She joins Anita to discuss being a young woman in the Church, making religion fun and connecting with a younger audience.Presenter: Anita Rani Producer: Rebecca Myatt

How to Ruin a Country | From a Nation of Immigrants to a Nation of Hate, Xenophobia, Exclusion and Cruelty | An Inside Look Into the Fateful Campaign That Brought Back Trump to Finish Off America Host: Ian Masters Producer: Graham FitzGibbon Assistant Producer: Asher Price

“Psychedelic medicine can be rocket fuel for healing,” explains Nick Brüss, EdD, LMFT. Brüss, licensed psychotherapist in Los Angeles specializing in integrative, ketamine-assisted psychotherapy, and Internal Family Systems, joins us today to discuss the healing power of psychedelic medicine, the therapeutic uses, plus:  - What is  psychedelic therapy (~2:03) - Use cases for psychedelic therapy (~7:15) -  MDMA, psilocybin, ketamine (~9:12) - Set & setting (~12:08) - MDMA (~15:35) - Ketamine (~21:33) -  Psilocybin (~27:40) - Opening up to the experience (~29:20) - Exclusion criteria (~32:10) - Age & brain development (~33:50) - Choosing a practitioner (~37:17) - Non-psychadelic modalities (~41:22) - Where is the science headed (~47:40) - What Brüss is most excited about (~49:55) - Closing thoughts (~52:50) Referenced in the episode:  - Check out his website (https://apracticeoffreedom.com/)  - Follow him on Instagram (@drnickbruss)  - Research by MAPS on MDMA (https://maps.org/mdma/ptsd/phase3/)  Set your kid's night routine up for success with Hyland's sleep-supporting gummies and sugar-free liquids. These multi-benefit formulas are made with or without melatonin to ease occasional sleeplessness while also supporting calm and immune health—so the whole family snoozes better.*‡ Learn more at hylands.com. We hope you enjoy this episode, and feel free to watch the full video on YouTube! Whether it's an article or podcast, we want to know what we can do to help here at mindbodygreen. Let us know at: podcast@mindbodygreen.com. *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. ‡ For occasional sleeplessness. Learn more about your ad choices. Visit megaphone.fm/adchoices